{
  "schema_version": "1.0.0",
  "title": "ACC/AHA Guideline for Carotid Artery Stenting",
  "organization": "American College of Cardiology / American Heart Association",
  "year": 2021,
  "version": "2021 Focused Update",
  "guideline_id": "ACC-AHA-CAS-2021",
  "metadata": {
    "doi": "10.1161/CIR.0000000000001025",
    "url": "https://www.acc.org/guidelines",
    "committee": "ACC/AHA Guideline Committee",
    "last_updated": "2021-07-01"
  },
  "indications": {
    "class_i": [
      {
        "indication": "Symptomatic carotid stenosis >50% (NASCET)",
        "description": "CAS is indicated for patients with recent TIA or ischemic stroke attributed to 50-99% stenosis of the internal carotid artery",
        "evidence_level": "Level A",
        "supporting_studies": ["CREST", "SAPPHIRE", "EVA-3S", "SPACE"],
        "patient_selection": "High surgical risk or preferred endovascular approach",
        "time_frame": "Symptoms within 6 months"
      },
      {
        "indication": "Symptomatic carotid stenosis >70% (NASCET)",
        "description": "CAS strongly indicated for symptomatic patients with >70% stenosis",
        "evidence_level": "Level A",
        "supporting_studies": ["NASCET", "ECST", "VA Cooperative Study"],
        "comparison": "Similar efficacy to CEA in appropriate patients"
      },
      {
        "indication": "Asymptomatic carotid stenosis >70% in high-risk patients",
        "description": "CAS may be considered for asymptomatic patients >70% stenosis with high surgical risk",
        "evidence_level": "Level B",
        "supporting_studies": ["ACT I", "CREST - asymptomatic cohort"],
        "considerations": "Life expectancy >3 years, low peri-procedural risk"
      }
    ],
    "class_iia": [
      {
        "indication": "Asymptomatic carotid stenosis >60%",
        "description": "CAS can be useful for asymptomatic patients 60-69% stenosis",
        "evidence_level": "Level B",
        "conditions": "Low peri-procedural risk, favorable anatomy"
      },
      {
        "indication": "Carotid restenosis after CEA",
        "description": "CAS is reasonable for patients with restenosis after prior endarterectomy",
        "evidence_level": "Level B",
        "rationale": "Avoids re-operation with potential nerve injury"
      },
      {
        "indication": "Radiation-induced stenosis",
        "description": "CAS is reasonable for radiation-induced carotid stenosis",
        "evidence_level": "Level B",
        "rationale": "High surgical risk with fibrotic tissue"
      },
      {
        "indication": "Contralateral carotid occlusion",
        "description": "CAS is reasonable in patients with contralateral ICA occlusion",
        "evidence_level": "Level B",
        "rationale": "CEA carries higher risk with no contralateral flow"
      },
      {
        "indication": "High cervical ICA lesions (C2-C3)",
        "description": "CAS may be preferred for lesions at or above C2 segment",
        "evidence_level": "Level C",
        "rationale": "Difficult surgical access"
      }
    ],
    "class_iii": [
      {
        "indication": "Non-disabling stroke with poor functional status",
        "description": "CAS not recommended for patients with modified Rankin score >2",
        "class": "III (No Benefit)",
        "evidence_level": "Level B",
        "rationale": "Limited functional benefit, high peri-procedural risk"
      },
      {
        "indication": "Chronic total occlusion of ICA",
        "description": "CAS should not be performed for chronic ICA occlusion",
        "class": "III (Harm)",
        "evidence_level": "Level B",
        "rationale": "High complication risk, low success rate"
      },
      {
        "indication": "Severe dementia",
        "description": "CAS not recommended for patients with severe dementia",
        "class": "III (No Benefit)",
        "evidence_level": "Level C",
        "rationale": "Unable to consent, limited benefit"
      }
    ]
  },
  "contraindications": {
    "absolute": [
      {
        "contraindication": "Non-correctable bleeding diathesis",
        "description": "Active bleeding or inability to tolerate antiplatelet therapy",
        "management": "Address bleeding risk before proceeding"
      },
      {
        "contraindication": "Uncontrolled hypertension",
        "description": "SBP >180 mmHg or DBP >110 mmHg",
        "management": "Optimize BP control before procedure"
      },
      {
        "contraindication": "Active infection or sepsis",
        "description": "Systemic infection increases complication risk",
        "management": "Treat infection before elective procedure"
      }
    ],
    "relative": [
      {
        "contraindication": "Age >80",
        "description": "Higher peri-procedural stroke risk in elderly",
        "consideration": "CEA may be preferred for patients >70-80 years",
        "evidence": "CREST age interaction"
      },
      {
        "contraindication": "Complex aortic arch anatomy",
        "description": "Type III arch, bovine arch, severe tortuosity",
        "consideration": "Increased technical difficulty, higher embolic risk",
        "management": "Consider experienced operator or CEA"
      },
      {
        "contraindication": "Thrombus-containing lesion",
        "description": "Visible thrombus on angiography",
        "consideration": "High embolic risk",
        "management": "Consider anticoagulation, delay procedure, or CEA"
      },
      {
        "contraindication": "Tandem lesions (ICA + MCA)",
        "description": "Significant intracranial stenosis in addition to ICA stenosis",
        "consideration": "Outcomes depend on intracranial disease",
        "management": "Address intracranial disease first or medical therapy"
      }
    ]
  },
  "procedural_recommendations": {
    "pre_procedural": {
      "imaging": {
        "required": [
          "Carotid duplex ultrasound - confirm stenosis severity",
          "CT angiography - assess anatomy and plaque morphology",
          "MRI brain - identify silent infarcts (if symptomatic)"
        ],
        "optional": [
          "Digital subtraction angiography - if non-invasive studies discordant",
          "Transcranial Doppler - assess collateral circulation"
        ]
      },
      "medication": {
        "dual_antiplatelet_therapy": {
          "aspirin": {
            "dose": "81-325 mg daily",
            "duration": "Start at least 3 days before procedure",
            "loading": "325 mg if not on aspirin (at least 24h before)"
          },
          "clopidogrel": {
            "dose": "75 mg daily",
            "duration": "Start at least 3-5 days before procedure",
            "loading": "300-600 mg (at least 24h before, preferably 72h)"
          },
          "resistance_testing": {
            "indication": "Consider if prior stent thrombosis or high-risk anatomy",
            "method": "VerifyNow or platelet aggregation",
            "alternative": "Ticagrelor or prasugrel if resistant"
          }
        },
        "statin": {
          "recommendation": "High-intensity statin pre-procedure",
          "class": "Class I",
          "evidence": "Level B"
        }
      }
    },
    "technical_aspects": {
      "embolic_protection": {
        "mandatory": {
          "class": "Class I",
          "evidence": "Level A",
          "description": "Embolic protection device should be used in all CAS procedures"
        },
        "device_types": {
          "distal_filter": {
            "usage": "Most common, first-line",
            "advantages": ["Continuous flow", "Familiar to operators"],
            "limitations": ["Cannot cross in 2-5%", "May miss debris before deployment"]
          },
          "proximal_occlusion": {
            "usage": "Alternative for tortuous anatomy or distal filter failure",
            "advantages": ["Protection before lesion crossing", "Higher debris capture"],
            "limitations": ["Requires flow reversal", "Patient discomfort"]
          }
        },
        "positioning": "Deploy 2-3 cm distal to lesion, in straight ICA segment"
      },
      "access_site": {
        "femoral": {
          "class": "Class I",
          "evidence": "Level A",
          "sheath_size": "6-8 Fr (typically 7 Fr)",
          "alternatives": "Radial or brachial if femoral not feasible"
        }
      },
      "stent_selection": {
        "closed_cell": {
          "advantages": ["Better plaque coverage", "Lower embolization risk", "Better radial strength"],
          "disadvantages": ["Less flexible", "Harder to track"],
          "indication": "Preferred for most lesions, especially ulcerated plaques"
        },
        "open_cell": {
          "advantages": ["More flexible", "Better conformability", "Easier to deliver"],
          "disadvantages": ["Less plaque coverage", "Potential for plaque prolapse"],
          "indication": "Tortuous vessels, difficult anatomy"
        },
        "sizing": {
          "diameter": "1-2 mm larger than normal distal ICA",
          "length": "Cover lesion with 5-10 mm margins proximal and distal"
        }
      },
      "post_dilatation": {
        "indication": "Suboptimal stent expansion",
        "caution": "Avoid high-pressure (>12 atm) dilatation, risk of embolization",
        "recommendation": "Use undersized balloon, check angiography before"
      }
    },
    "intra_procedural": {
      "anticoagulation": {
        "heparin": {
          "dosing": "70-100 U/kg bolus",
          "target_act": ">250 seconds",
          "monitoring": "ACT every 30 minutes",
          "class": "Class I",
          "evidence": "Level C"
        }
      },
      "hemodynamic_management": {
        "bradycardia": {
          "cause": "Carotid sinus stimulation",
          "prevention": "Atropine 0.5-1 mg available before balloon inflation",
          "treatment": "Atropine 0.5-1 mg IV, may repeat"
        },
        "hypotension": {
          "cause": "Carotid sinus reflex, vasovagal",
          "prevention": "Gentile wire manipulation",
          "treatment": "Phenylephrine 100-200 mcg IV, IV fluids"
        }
      }
    }
  },
  "post_procedure_care": {
    "immediate_post_procedure": {
      "monitoring": {
        "duration": "At least 18-24 hours observation",
        "neurological_checks": "Every hour for first 6 hours, then every 4 hours",
        "vital_signs": "Continuous cardiac monitoring, BP monitoring",
        "hemodynamic": "Watch for hypotension or hypertension"
      },
      "blood_pressure_control": {
        "target": "SBP <140 mmHg, DBP <90 mmHg",
        "urgency": "Class I",
        "evidence": "Level A",
        "rationale": "Prevent hyperperfusion syndrome and hemorrhage"
      }
    },
    "dual_antiplatelet_therapy": {
      "duration": {
        "minimum": "30 days",
        "optimal": "4-6 weeks",
        "aspirin": "Lifelong (81-325 mg daily)",
        "clopidogrel": "75 mg daily for minimum 30 days"
      },
      "class": "Class I",
      "evidence": "Level A"
    },
    "follow_up": {
      "schedule": [
        {
          "timeframe": "30 days",
          "assessments": ["Clinical evaluation", "Duplex ultrasound", "Medication adherence"]
        },
        {
          "timeframe": "6 months",
          "assessments": ["Clinical evaluation", "Duplex ultrasound", "Restenosis screening"]
        },
        {
          "timeframe": "12 months and annually",
          "assessments": ["Clinical evaluation", "Duplex ultrasound"]
        }
      ]
    },
    "secondary_prevention": {
      "statin_therapy": {
        "intensity": "High-intensity (atorvastatin 40-80mg or rosuvastatin 20-40mg)",
        "target_ldl": "<70 mg/dL (preferably <55 mg/dL)",
        "class": "Class I",
        "evidence": "Level A"
      },
      "risk_factor_modification": {
        "smoking": "Cessation counseling and support",
        "diabetes": "HbA1c <7%",
        "hypertension": "BP <140/90 mmHg",
        "weight": "BMI 18.5-25 kg/mÂ²",
        "exercise": "150 minutes moderate activity per week"
      }
    }
  },
  "complications": {
    "peri_procedural_stroke": {
      "incidence": "3-5% overall",
      "risk_factors": [
        "Age >70",
        "Symptomatic status",
        "Complex anatomy",
        "No EPD use",
        "Long lesions (>15mm)",
        "Tandem lesions"
      ],
      "prevention": [
        "Universal EPD use",
        "Careful technique",
        "Pre-procedure DAPT",
        "Operator experience"
      ],
      "types": {
        "ischemic": "Embolic - 80% of strokes",
        "hemorrhagic": "Hyperperfusion - 20% of strokes"
      }
    },
    "hyperperfusion_syndrome": {
      "incidence": "1-2%",
      "onset": "Hours to days post-procedure",
      "symptoms": [
        " ipsilateral headache",
        "Facial or eye pain",
        "Seizures",
        "Altered mental status",
        "Focal neurological deficit"
      ],
      "risk_factors": [
        "High-grade stenosis (>90%)",
        "Poor collateral circulation",
        "Poorly controlled hypertension",
        "Contralateral ICA occlusion"
      ],
      "prevention": {
        "bp_control": "Critical - SBP <140 mmHg",
        "monitoring": "Neurological checks, educate patient on symptoms"
      },
      "treatment": {
        "immediate": "Strict BP control (SBP <120-140 mmHg)",
        "medications": ["Labetalol", "Nicardipine", "Clevidipine"],
        "severe": "ICU monitoring, consider antiepileptic if seizures"
      }
    },
    "access_site_complications": {
      "incidence": "5-7%",
      "types": [
        {
          "type": "Hematoma",
          "treatment": "Compression, observation"
        },
        {
          "type": "Pseudoaneurysm",
          "treatment": "Thrombin injection, compression, or surgical repair"
        },
        {
          "type": "Retroperitoneal bleed",
          "treatment": "Resuscitation, stent graft or surgery if severe"
        }
      ],
      "prevention": [
        "Ultrasound-guided access",
        "Micropuncture technique",
        "Proper sheath management",
        "Adequate hemostasis"
      ]
    },
    "cranial_nerve_injury": {
      "incidence": "<1% (vs 5-10% for CEA)",
      "nerves": [
        "Hypoglossal (XII) - tongue deviation",
        "Recurrent laryngeal - hoarseness",
        "Marginal mandibular - facial droop"
      ],
      "course": "Usually transient, resolves within weeks to months"
    }
  },
  "operator_and_institutional_requirements": {
    "minimum_case_volume": {
      "operator": ">12 CAS procedures per year or >30 lifetime cases",
      "institution": ">24 CAS procedures per year with good outcomes"
    },
    "training": {
      "recommended": "Dedicated CAS training program, proctoring for early cases",
      "requirements": ["Familiarity with EPD devices", "Experience in carotid and cerebral angiography"]
    },
    "outcomes_tracking": {
      "benchmark_stroke_death": "<6% for symptomatic, <3% for asymptomatic",
      "regular_review": "Quarterly morbidity and mortality review"
    }
  },
  "comparison_with_cea": {
    "crest_trial": {
      "no_difference": "Overall periprocedural stroke/death/myocardial infarction similar",
      "age_interaction": {
        "under_70": "CAS better - lower MI risk",
        "over_70": "CEA better - lower stroke risk"
      },
      "stroke_vs_mi": {
        "cas": "Higher stroke risk (4.1% vs 2.3%)",
        "cea": "Higher MI risk (2.3% vs 1.1%)"
      }
    },
    "selection_considerations": {
      "cas_preferred": [
        "High surgical risk (prior neck surgery, radiation)",
        "High cervical lesion",
        "Contralateral carotid occlusion",
        "Tracheostomy or high cervical spinal injury",
        "Age <70 (based on CREST)"
      ],
      "cea_preferred": [
        "Age >70-80",
        "Type III aortic arch",
        "Severe arch calcification",
        "Tandem proximal common carotid disease",
        "Long, tortuous ICA"
      ]
    }
  },
  "emerging_techniques": {
    "transcarotid_revascularization": {
      "description": "TCAR - hybrid approach with carotid cutdown and flow reversal",
      "potential_advantages": ["Avoids aortic arch navigation", "Continuous embolic protection"],
      "current_status": "Growing evidence, alternative to CAS and CEA",
      "evidence": "ROADSTER trials"
    }
  }
}
